SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders

Continues to Recommend Stockholders Vote “FOR” Pending Merger ISS has Dismissed Madryn’s Misleading Claims and Reaffirms that Stockholders Vote “FOR” the Merger BOULDER, Colo., Dec. 29, 2023 /PRNewswire/ — SomaLogic, Inc. (Nasdaq: SLGC) (“the Company”), a leader in proteomics technology,…

Click here to view original post